NCT04222972 2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3 Terminated
Clinical Trials
36 trialsNCT05386550 2026-02-19
Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)
EMD Serono
Phase 3 Terminated
NCT04459715 2025-10-08
A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)
EMD Serono
Phase 3 Terminated
NCT04458909 2025-10-03
Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer
National Cancer Institute (NCI)
Phase 3 Terminated
NCT02363400 2025-08-19
A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA
National Health Research Institutes, Taiwan
Phase 3 Terminated
NCT05142904 2025-07-17
RABITO
Rijnstate Hospital
Phase 3 Terminated
NCT05930938 2025-05-09
XXL_2022-01
Groupe Oncologie Radiotherapie Tete et Cou
Phase 3 Terminated
NCT04176419 2024-11-12
Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery
Case Comprehensive Cancer Center
Phase 3 Terminated
NCT04428333 2024-10-09
INDUCE-4
GlaxoSmithKline
Phase 3 Terminated
NCT04128696 2024-07-10
INDUCE-3
GlaxoSmithKline
Phase 3 Terminated
NCT00198328 2022-03-04
Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma
Inovio Pharmaceuticals
Phase 3 Terminated
NCT03602495 2021-12-13
DTC
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 3 Terminated
NCT02952586 2021-09-22
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Pfizer
Phase 3 Terminated
NCT03682367 2021-07-09
Perioperative Analgesia Using Gabapentin in Head and Neck Cancer Surgery
University of California, Davis
Phase 3 Terminated
NCT01126216 2021-05-04
Paccis-RCT
University of Erlangen-Nürnberg Medical School
Phase 3 Terminated
NCT01843062 2019-08-28
ASTRA
AstraZeneca
Phase 3 Terminated
NCT02137096 2019-06-24
Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma
University of Florida
Phase 3 Terminated
NCT00828386 2019-01-18
NPC2006
Groupe Oncologie Radiotherapie Tete et Cou
Phase 3 Terminated
NCT03637335 2018-08-20
METAXIOM
Institut Cancerologie de l'Ouest
Phase 3 Terminated
NCT01345669 2017-12-07
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Boehringer Ingelheim
Phase 3 Terminated
NCT02655068 2017-07-31
Phase III Trial of PET/CT vs. CTSurveilance for Head and Neck Cancer
University of Pittsburgh
Phase 3 Terminated
NCT00412217 2016-11-25
A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer
Hoffmann-La Roche
Phase 3 Terminated
NCT00537199 2016-05-13
OraTest in Combination With Visual Examination and Visual Examination Alone
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT01161498 2016-02-08
Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer
BioVex Limited
Phase 3 Terminated
NCT00006994 2015-11-18
S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
SWOG Cancer Research Network
Phase 3 Terminated
NCT00088907 2015-05-06
Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer
National Cancer Institute (NCI)
Phase 3 Terminated
NCT00911326 2014-08-08
Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
Navidea Biopharmaceuticals
Phase 3 Terminated
NCT02183246 2014-07-08
Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients
Boehringer Ingelheim
Phase 3 Terminated
NCT00004227 2014-02-06
Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
University of Alabama at Birmingham
Phase 3 Terminated
NCT00574860 2013-09-20
EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer
Endo Pharmaceuticals
Phase 3 Terminated
NCT00113399 2013-07-02
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
Radiation Therapy Oncology Group
Phase 3 Terminated
NCT00128817 2013-01-23
Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal Cancers
Tata Memorial Hospital
Phase 3 Terminated
NCT01066741 2012-11-01
Prevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum Cancer
Centre Leon Berard
Phase 3 Terminated
NCT00268372 2012-10-04
S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx
SWOG Cancer Research Network
Phase 3 Terminated
NCT00017277 2012-09-24
Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Terminated
NCT00201344 2010-03-26
A Phase III Study of Radiotherapy With or Without Adjuvant C/T in Advanced Stage Nasopharyngeal Carcinoma Patients
National Health Research Institutes, Taiwan
Phase 3 Terminated